Cigna earnings beat by $0.04, revenue topped estimates
NEW YORK—Sarah Ann Fay, a director at Ziff Davis, Inc. (NASDAQ:ZD), recently acquired 1,282 shares of the company’s common stock. The transaction, valued at approximately $49,998, was completed on March 4, 2025, at a price of $39 per share. Following this purchase, Fay holds a total of 18,655 shares in the company. This insider purchase comes as InvestingPro analysis shows the stock trading significantly below its Fair Value, with impressive gross profit margins of 86%.
The transaction was reported in a Form 4 filing with the Securities and Exchange Commission, underscoring Fay’s ongoing investment in the company. Ziff Davis, headquartered in New York, operates in the telegraph and other message communications industry. The $1.69B market cap company has seen its stock decline 42% over the past year, while management has been actively buying back shares. For deeper insights into insider trading patterns and 14+ additional ProTips, visit InvestingPro.
In other recent news, Ziff Davis Inc. reported its financial results for the fourth quarter of 2024, revealing an adjusted diluted earnings per share (EPS) of $2.58, slightly above the forecast of $2.57. Despite this earnings beat, the company fell short on revenue, recording $412.8 million against an expected $423.87 million. The company’s full-year revenue reached $1.401 billion, marking a 2.8% increase from the previous year, while adjusted EBITDA for the quarter was $171.8 million, up 2.5% year-over-year. Citi analysts have adjusted their outlook on Ziff Davis, reducing the price target from $58.00 to $52.00, while maintaining a Neutral rating on the company’s shares. This adjustment followed a review of Ziff Davis’s fourth-quarter results and full-year 2025 guidance, which showed a mix of positive developments and challenges. The company is optimistic about 2025, expecting growth across all five segments, driven by new product launches and strategic initiatives, although the first quarter is anticipated to be weaker. Additionally, potential risks associated with GenAI Search could impact Ziff Davis’s performance, despite the company not experiencing any traffic or click-through rate headwinds so far.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.